Galectin Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $20k | 4.3k | 4.64 |
| 2025-03-31 | $2.4k | 2.0k | 1.22 |
| 2024-12-31 | $2.6k | 2.0k | 1.29 |
| 2024-09-30 | $5.5k | 2.0k | 2.75 |
| 2024-06-30 | $4.5k | 2.0k | 2.26 |
| 2021-03-31 | $6.0k | 2.8k | 2.11 |
| 2020-12-31 | $6.0k | 2.8k | 2.11 |
| 2020-09-30 | $8.0k | 2.8k | 2.81 |
| 2020-06-30 | $9.0k | 2.8k | 3.16 |
| 2020-03-31 | $6.0k | 2.8k | 2.11 |
| 2019-12-31 | $8.0k | 2.8k | 2.81 |
| 2019-09-30 | $10k | 2.8k | 3.51 |
| 2019-06-30 | $12k | 2.8k | 4.22 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors